FDA
-
-
-
-
-
-
-
Exact Sciences presents colorectal cancer screening data at ACG 2025
-
-
-
-
-
-
-
Exact Sciences (EXAS) PT Lowered at TD Cowen; 'Sell-Off Looks Overdone'
-
-
-
-
-
-
-
Exact Sciences to Highlight CologuardĀ® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
-
-
-
-
-
-
-
Is Trump 2.0 good or bad for healthcare stocks?
-
-
-
-
-
-
-
Exact Sciences (EXAS) PT Raised to $95 at Canaccord Genuity
-
-
-
-
-
-
-
Exact Sciences (EXAS) Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
-
-
-
-
-
-
-
Exact Sciences (EXAS) Slips 5% After Rival Colorectal Cancer Test Approved by FDA
-
322,899 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

